[PCRX] YoY Quarter Result on 30-Sep-2023 [#Q3]

Stock
[PCRX] Pacira BioSciences, Inc.
Announcement Date
02-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- -57.85%
YoY- 1,666.81%
Quarter Report
PCRX's Result
PCRX's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Revenue 168,573 163,926 167,466 127,722 117,484 104,685 83,448 12.42%
PBT -138,856 16,601 2,069 24,231 6,150 -5,816 -702 141.18%
Tax -4,610 5,743 2,762 6,571 -123,969 271 -62 104.92%
NP -143,466 10,858 -693 17,660 130,119 -6,087 -640 146.26%
Tax Rate - -34.59% -133.49% -27.12% 2,015.76% - - -
Total Cost 312,039 153,068 168,159 110,062 -12,635 110,772 84,088 24.40%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
NP Margin -85.11 6.62 -0.41 13.83 110.75 -5.81 -0.77 118.91%
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
EPS -3.11 0.23 -0.02 0.40 3.03 -0.15 -0.02 131.71%
EPS Diluted -3.11 0.23 -0.02 0.39 2.94 -0.15 -0.02 131.71%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.